Bradley L. Radoff - 09 Jan 2023 Form 4 Insider Report for Guardion Health Sciences, Inc.

Role
10%+ Owner
Signature
/s/ Bradley L. Radoff
Issuer symbol
N/A
Transactions as of
09 Jan 2023
Net transactions value
+$825,840
Form type
4
Filing time
11 Jan 2023, 16:11:40 UTC
Previous filing
07 Oct 2022
Next filing
13 Feb 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GHSI Common Stock Purchase $433,562 +63,983 +63% $6.78 165,162 09 Jan 2023 Direct F1, F2
transaction GHSI Common Stock Purchase $149,925 +20,838 +13% $7.19 186,000 09 Jan 2023 Direct F1, F3
transaction GHSI Common Stock Purchase $136,208 +18,630 +10% $7.31 204,630 10 Jan 2023 Direct F1, F4
transaction GHSI Common Stock Purchase $106,145 +13,270 +6.5% $8.00 217,900 10 Jan 2023 Direct F1, F5
holding GHSI Common Stock 25,100 09 Jan 2023 By The Radoff Family Foundation F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.
F2 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.7762 to $7.0417 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
F3 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.05 to $7.48 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
F4 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.75 to $7.70 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
F5 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.97 to $8.00 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
F6 Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.